Keyphrases
Recombinant
100%
Gaucher Disease
100%
Lipid Nanoparticles
100%
Brain Delivery
100%
Glucocerebrosidase
100%
Therapeutic Modalities
40%
Neuronopathy
40%
Enzyme Replacement Therapy
40%
Substrate Reduction Therapy
40%
Injected Dose
40%
Novel Therapeutics
20%
Blood-brain Barrier
20%
Phospholipids
20%
Skin Fibroblasts
20%
Brain Parenchyma
20%
Early Death
20%
Young Patients
20%
Encapsulated Enzyme
20%
Free Enzyme
20%
Alzheimer
20%
Parkinson
20%
Monocyte-derived Cells
20%
Zwitterion
20%
First Year of Life
20%
Glucocerebrosidase Activity
20%
Glucosylceramide
20%
Visceral Disease
20%
Therapy Reduction
20%
Lysosomal Storage Disease
20%
CD11b+ Cells
20%
Pharmacology, Toxicology and Pharmaceutical Science
Gaucher's Disease
100%
Glucosylceramidase
100%
Solid Lipid Nanoparticle
100%
Diseases
80%
Replacement Therapy
40%
Phospholipid
20%
Glucosylceramide
20%
Zwitterion
20%
Lysosome Storage Disease
20%
Blood-Brain Barrier
20%
Immunology and Microbiology
Parenchyma
100%
Blood Brain Barrier
100%
Target Cell
100%
Skin Fibroblast
100%
Neuroscience
Glucosylceramidase
100%
Enzyme Replacement Therapy
50%
Blood Brain Barrier
25%
Parenchyma
25%
Phospholipid
25%
Glucosylceramide
25%
Zwitterion
25%
Fibroblast
25%